highmark glp-1 coverage BCBSM pulling back on Highmark Blue Cross Blue Shield

The drug was approved by the US FDA in June 2021 as a 2.4 mg once-weekly injection for chronic weight management in adults with obesity or those overweight with at least one weight-related condition, such as high blood pressure, Type 2 diabetes or high cholesterol.3 In 2023, according to market information from Midas (IQVIA), sales of semaglutide for weight management more than quadrupled year-on-year, and further interest has been spurred by new indications related to reducing cardiovascular risk, and emerging benefits are being shown in people with Alzheimers disease.4,5 The strength of these figures clearly demonstrates the intense demand for GLP-1 treatments, but it does not convey the unforeseen implications of such high levels of popularity

GLP-1, or glucagon-like peptide-1, is a hormone that helps to regulate appetite and blood sugar in the body

This article starts with the confirmed Supplement Facts label because that's where the real story is

In addition, people with a BMI of 27 to 30 kg/m 2 , along with one or more weight-related conditions (such as high blood pressure, high cholesterol, or diabetes) will also benefit and may qualify for insurance coverage, but it is best to contact your insurance provider for coverage details

When to Consult Your Healthcare Provider While feeling cold is usually a sign that your body is adapting to weight loss, you should always keep an open line of communication with a medical professional